Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-01

Clinical Trial Update: A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating soticlestat as add-on therapy in children and young adults with Dravet syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soticlestat (soticlestat)

Snippet

Sponsor: Takeda | Conditions: Dravet Syndrome (DS) | Phase 3 | Status: COMPLETED | Results posted: 2025-01-01